Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
AR-V7 positive
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
AR-V7 positive
Renal Cell Carcinoma
AR-V7 positive
Renal Cell Carcinoma
abiraterone acetate
Resistant: C3 – Early Trials
abiraterone acetate
Resistant
:
C3
abiraterone acetate
Resistant: C3 – Early Trials
abiraterone acetate
Resistant
:
C3
AR-V7 positive
Prostate Cancer
AR-V7 positive
Prostate Cancer
cabazitaxel
Sensitive: C3 – Early Trials
cabazitaxel
Sensitive
:
C3
cabazitaxel
Sensitive: C3 – Early Trials
cabazitaxel
Sensitive
:
C3
AR-V7 positive
Prostate Cancer
AR-V7 positive
Prostate Cancer
docetaxel
Sensitive: C3 – Early Trials
docetaxel
Sensitive
:
C3
docetaxel
Sensitive: C3 – Early Trials
docetaxel
Sensitive
:
C3
AR-V7 positive
Prostate Cancer
AR-V7 positive
Prostate Cancer
abiraterone acetate
Resistant: C3 – Early Trials
abiraterone acetate
Resistant
:
C3
abiraterone acetate
Resistant: C3 – Early Trials
abiraterone acetate
Resistant
:
C3
AR-V7 positive
Prostate Cancer
AR-V7 positive
Prostate Cancer
enzalutamide capsule
Resistant: C3 – Early Trials
enzalutamide capsule
Resistant
:
C3
enzalutamide capsule
Resistant: C3 – Early Trials
enzalutamide capsule
Resistant
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
